Gene · 3594
Papers2,084
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,084
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial. | Nat Commun | 2023 | 37739939 | PubTator, text mining | PubMed |
| Paradoxical psoriasis: The flip side of idiopathic psoriasis or an autocephalous reversible drug reaction? | J Transl Autoimmun | 2023 | 37731549 | PubTator, text mining | PubMed |
| Down-regulation of interleukin-2 predicts poor prognosis and associated with immune escape in lung adenocarcinoma. | Int J Immunopathol Pharmacol | 2023 | 37731383 | PubTator, text mining | PubMed |
| Interleukin-23 Involved in Fibrotic Autoimmune Diseases: New Discoveries. | J Clin Med | 2023 | 37685766 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Mechanisms of Psoriasis. | Genes (Basel) | 2023 | 37628670 | PubTator, text mining | PubMed |
| Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis. | Nat Commun | 2023 | 37612267 | PubTator, text mining | PubMed |
| Emerging Therapies for Ulcerative Colitis: Updates from Recent Clinical Trials. | Clin Exp Gastroenterol | 2023 | 37609124 | PubTator, text mining | PubMed |
| Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer. | J Immunother Cancer | 2023 | 37607770 | PubTator, text mining | PubMed |
| Mechanism and clinical evidence of immunotherapy in allergic rhinitis. | Front Allergy | 2023 | 37601646 | PubTator, text mining | PubMed |
| The chromatin and single-cell transcriptional landscapes of CD4 T cells in inflammatory bowel disease link risk loci with a proinflammatory Th17 cell population. | Front Immunol | 2023 | 37600767 | PubTator, text mining | PubMed |
| Hemophagocytic Lymphohistiocytosis (HLH) Due to Fulminant Salmonella Sepsis in the Setting of IL12Rβ1 (Interleukin 12 Receptor Beta 1) Deficiency. | Cureus | 2023 | 37588305 | PubTator, text mining | PubMed |
| The PCOS-NAFLD Multidisease Phenotype Occurred in Medaka Fish Four Generations after the Removal of Bisphenol A Exposure. | Environ Sci Technol | 2023 | 37581432 | PubTator, text mining | PubMed |
| Challenges of Diagnosing Mendelian Susceptibility to Mycobacterial Diseases in South Africa. | Int J Mol Sci | 2023 | 37569495 | PubTator, text mining | PubMed |
| Metabolites and Immune Response in Tumor Microenvironments. | Cancers (Basel) | 2023 | 37568713 | PubTator, text mining | PubMed |
| A half-century of research on tuberculosis: Successes and challenges. | J Exp Med | 2023 | 37552470 | PubTator, text mining | PubMed |
| CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers. | Science | 2023 | 37535729 | PubTator, text mining | PubMed |
| Which is the Ideal JAK Inhibitor for Alopecia Areata - Baricitinib, Tofacitinib, Ritlecitinib or Ifidancitinib - Revisiting the Immunomechanisms of the JAK Pathway. | Indian Dermatol Online J | 2023 | 37521227 | PubTator, text mining | PubMed |
| Candidate Gene Association Studies in Atopic Dermatitis in Participants of European and Asian Ancestry: A Systematic Review and Meta-Analysis. | Genes (Basel) | 2023 | 37510360 | PubTator, text mining | PubMed |
| Changes in expression levels of erythrocyte and immune-related genes are associated with high altitude polycythemia. | BMC Med Genomics | 2023 | 37507679 | PubTator, text mining | PubMed |
| Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models. | J Transl Med | 2023 | 37501121 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3594/papers?page=8